Worldwide Prevalence of <i>mcr</i>-mediated Colistin-Resistance <i>Escherichia coli</i> in Isolates of Clinical Samples, Healthy Humans, and Livestock—A Systematic Review and Meta-Analysis

<b>Background:</b> Antimicrobial resistance is a serious public-health problem throughout the world. <i>Escherichia coli</i>, the most common Gram-negative microorganism, has developed different resistance mechanisms, making treating infections difficult. Colistin is consider...

Full description

Bibliographic Details
Main Authors: Carlos Bastidas-Caldes, Jacobus H. de Waard, María Soledad Salgado, María José Villacís, Marco Coral-Almeida, Yoshimasa Yamamoto, Manuel Calvopiña
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/11/6/659
_version_ 1827657712644653056
author Carlos Bastidas-Caldes
Jacobus H. de Waard
María Soledad Salgado
María José Villacís
Marco Coral-Almeida
Yoshimasa Yamamoto
Manuel Calvopiña
author_facet Carlos Bastidas-Caldes
Jacobus H. de Waard
María Soledad Salgado
María José Villacís
Marco Coral-Almeida
Yoshimasa Yamamoto
Manuel Calvopiña
author_sort Carlos Bastidas-Caldes
collection DOAJ
description <b>Background:</b> Antimicrobial resistance is a serious public-health problem throughout the world. <i>Escherichia coli</i>, the most common Gram-negative microorganism, has developed different resistance mechanisms, making treating infections difficult. Colistin is considered a last-resort drug in the treatment of infections caused by <i>E. coli</i>. Plasmid-mediated mobile-colistin-resistant (<i>mcr</i>) genes in <i>E. coli</i>, now disseminated globally, are considered a major public-health threat. Humans, chickens, and pigs are the main reservoirs for <i>E. coli</i> and the sources of antibiotic resistance. Hence, an up-to-date and precise estimate of the global prevalence of <i>mcr</i> resistance genes in these reservoirs is necessary to understand more precisely the worldwide spread and to more effectively implement control and prevention strategies. <b>Methodology</b>: Publications were identified in the PubMed database on the basis of the PRISMA guidelines. English full-text articles were selected from December 2014 to March 2021. Descriptive statistics and a meta-analysis were performed in Excel and R software, respectively. Colistin resistance was defined as the molecular-genetic detection of the <i>mcr</i> genes. The crude and estimated prevalence were calculated for each host and continent. The studies were divided into two groups; community-based when they involved isolates from healthy humans, chickens, or pigs, and clinical studies when they involved only hospital, outpatient, or laboratory isolates. <b>Results</b>: A total of 1278 studies were identified and 218 were included in this systematic review and meta-analysis, divided into community studies (159 studies) and clinical studies (59 studies). The general prevalence of <i>mcr</i>-mediated colistin-resistant <i>E. coli</i> (<b>mcrMCRE</b>) was 6.51% (n = 11,583/177,720), reported in 54 countries and on five continents; Asia with 119 studies followed by Europe with 61 studies registered the most articles. Asia reported the major diversity of <i>mcr</i>-variants (eight of nine, except <i>mcr-2</i>). Worldwide, chickens and pigs proved to be the principal reservoir of <i>mcr</i> with an estimated prevalence of 15.8% and 14.9%, respectively. Healthy humans and clinical isolates showed a lower prevalence with 7.4% and 4.2% respectively. <b>Conclusions</b>: In this systematic review and meta-analysis, the worldwide prevalence of <i>mcr</i> in <i>E. coli</i> isolated from healthy humans, chickens, and pigs was investigated. A wide prevalence and distribution of <i>mcr</i> genes was demonstrated on all continents in <i>E. coli</i> isolates from the selected reservoirs. Understanding the epidemiology and occurrence in the reservoirs of <i>mcr</i> in <i>E. coli</i> on different continents of the world facilitates tracing how <i>mcr</i> genes are transmitted and determining the infection risks for humans. This knowledge can be used to reduce the incidence of zoonotic transmission by implementing the appropriate control programs.
first_indexed 2024-03-09T22:48:51Z
format Article
id doaj.art-e721c36f667b477b9262f0c126434739
institution Directory Open Access Journal
issn 2076-0817
language English
last_indexed 2024-03-09T22:48:51Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series Pathogens
spelling doaj.art-e721c36f667b477b9262f0c1264347392023-11-23T18:24:50ZengMDPI AGPathogens2076-08172022-06-0111665910.3390/pathogens11060659Worldwide Prevalence of <i>mcr</i>-mediated Colistin-Resistance <i>Escherichia coli</i> in Isolates of Clinical Samples, Healthy Humans, and Livestock—A Systematic Review and Meta-AnalysisCarlos Bastidas-Caldes0Jacobus H. de Waard1María Soledad Salgado2María José Villacís3Marco Coral-Almeida4Yoshimasa Yamamoto5Manuel Calvopiña6One Health Research Group, Faculty of Engineering and Applied Sciences, Biotechnology Section, Universidad de Las Américas, Quito 170124, EcuadorOne Health Research Group, Faculty of Health Sciences, Universidad de Las Américas, Quito 170124, EcuadorOne Health Research Group, Faculty of Engineering and Applied Sciences, Biotechnology Section, Universidad de Las Américas, Quito 170124, EcuadorOne Health Research Group, Faculty of Engineering and Applied Sciences, Biotechnology Section, Universidad de Las Américas, Quito 170124, EcuadorOne Health Research Group, Faculty of Health Sciences, Universidad de Las Américas, Quito 170124, EcuadorThe United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, Gifu 501-1193, JapanOne Health Research Group, Faculty of Health Sciences, Universidad de Las Américas, Quito 170124, Ecuador<b>Background:</b> Antimicrobial resistance is a serious public-health problem throughout the world. <i>Escherichia coli</i>, the most common Gram-negative microorganism, has developed different resistance mechanisms, making treating infections difficult. Colistin is considered a last-resort drug in the treatment of infections caused by <i>E. coli</i>. Plasmid-mediated mobile-colistin-resistant (<i>mcr</i>) genes in <i>E. coli</i>, now disseminated globally, are considered a major public-health threat. Humans, chickens, and pigs are the main reservoirs for <i>E. coli</i> and the sources of antibiotic resistance. Hence, an up-to-date and precise estimate of the global prevalence of <i>mcr</i> resistance genes in these reservoirs is necessary to understand more precisely the worldwide spread and to more effectively implement control and prevention strategies. <b>Methodology</b>: Publications were identified in the PubMed database on the basis of the PRISMA guidelines. English full-text articles were selected from December 2014 to March 2021. Descriptive statistics and a meta-analysis were performed in Excel and R software, respectively. Colistin resistance was defined as the molecular-genetic detection of the <i>mcr</i> genes. The crude and estimated prevalence were calculated for each host and continent. The studies were divided into two groups; community-based when they involved isolates from healthy humans, chickens, or pigs, and clinical studies when they involved only hospital, outpatient, or laboratory isolates. <b>Results</b>: A total of 1278 studies were identified and 218 were included in this systematic review and meta-analysis, divided into community studies (159 studies) and clinical studies (59 studies). The general prevalence of <i>mcr</i>-mediated colistin-resistant <i>E. coli</i> (<b>mcrMCRE</b>) was 6.51% (n = 11,583/177,720), reported in 54 countries and on five continents; Asia with 119 studies followed by Europe with 61 studies registered the most articles. Asia reported the major diversity of <i>mcr</i>-variants (eight of nine, except <i>mcr-2</i>). Worldwide, chickens and pigs proved to be the principal reservoir of <i>mcr</i> with an estimated prevalence of 15.8% and 14.9%, respectively. Healthy humans and clinical isolates showed a lower prevalence with 7.4% and 4.2% respectively. <b>Conclusions</b>: In this systematic review and meta-analysis, the worldwide prevalence of <i>mcr</i> in <i>E. coli</i> isolated from healthy humans, chickens, and pigs was investigated. A wide prevalence and distribution of <i>mcr</i> genes was demonstrated on all continents in <i>E. coli</i> isolates from the selected reservoirs. Understanding the epidemiology and occurrence in the reservoirs of <i>mcr</i> in <i>E. coli</i> on different continents of the world facilitates tracing how <i>mcr</i> genes are transmitted and determining the infection risks for humans. This knowledge can be used to reduce the incidence of zoonotic transmission by implementing the appropriate control programs.https://www.mdpi.com/2076-0817/11/6/659colistinresistance<i>mcr</i><i>Escherichia coli</i>clinicalcommunity
spellingShingle Carlos Bastidas-Caldes
Jacobus H. de Waard
María Soledad Salgado
María José Villacís
Marco Coral-Almeida
Yoshimasa Yamamoto
Manuel Calvopiña
Worldwide Prevalence of <i>mcr</i>-mediated Colistin-Resistance <i>Escherichia coli</i> in Isolates of Clinical Samples, Healthy Humans, and Livestock—A Systematic Review and Meta-Analysis
Pathogens
colistin
resistance
<i>mcr</i>
<i>Escherichia coli</i>
clinical
community
title Worldwide Prevalence of <i>mcr</i>-mediated Colistin-Resistance <i>Escherichia coli</i> in Isolates of Clinical Samples, Healthy Humans, and Livestock—A Systematic Review and Meta-Analysis
title_full Worldwide Prevalence of <i>mcr</i>-mediated Colistin-Resistance <i>Escherichia coli</i> in Isolates of Clinical Samples, Healthy Humans, and Livestock—A Systematic Review and Meta-Analysis
title_fullStr Worldwide Prevalence of <i>mcr</i>-mediated Colistin-Resistance <i>Escherichia coli</i> in Isolates of Clinical Samples, Healthy Humans, and Livestock—A Systematic Review and Meta-Analysis
title_full_unstemmed Worldwide Prevalence of <i>mcr</i>-mediated Colistin-Resistance <i>Escherichia coli</i> in Isolates of Clinical Samples, Healthy Humans, and Livestock—A Systematic Review and Meta-Analysis
title_short Worldwide Prevalence of <i>mcr</i>-mediated Colistin-Resistance <i>Escherichia coli</i> in Isolates of Clinical Samples, Healthy Humans, and Livestock—A Systematic Review and Meta-Analysis
title_sort worldwide prevalence of i mcr i mediated colistin resistance i escherichia coli i in isolates of clinical samples healthy humans and livestock a systematic review and meta analysis
topic colistin
resistance
<i>mcr</i>
<i>Escherichia coli</i>
clinical
community
url https://www.mdpi.com/2076-0817/11/6/659
work_keys_str_mv AT carlosbastidascaldes worldwideprevalenceofimcrimediatedcolistinresistanceiescherichiacoliiinisolatesofclinicalsampleshealthyhumansandlivestockasystematicreviewandmetaanalysis
AT jacobushdewaard worldwideprevalenceofimcrimediatedcolistinresistanceiescherichiacoliiinisolatesofclinicalsampleshealthyhumansandlivestockasystematicreviewandmetaanalysis
AT mariasoledadsalgado worldwideprevalenceofimcrimediatedcolistinresistanceiescherichiacoliiinisolatesofclinicalsampleshealthyhumansandlivestockasystematicreviewandmetaanalysis
AT mariajosevillacis worldwideprevalenceofimcrimediatedcolistinresistanceiescherichiacoliiinisolatesofclinicalsampleshealthyhumansandlivestockasystematicreviewandmetaanalysis
AT marcocoralalmeida worldwideprevalenceofimcrimediatedcolistinresistanceiescherichiacoliiinisolatesofclinicalsampleshealthyhumansandlivestockasystematicreviewandmetaanalysis
AT yoshimasayamamoto worldwideprevalenceofimcrimediatedcolistinresistanceiescherichiacoliiinisolatesofclinicalsampleshealthyhumansandlivestockasystematicreviewandmetaanalysis
AT manuelcalvopina worldwideprevalenceofimcrimediatedcolistinresistanceiescherichiacoliiinisolatesofclinicalsampleshealthyhumansandlivestockasystematicreviewandmetaanalysis